In recent years, significant progress has been made in multidimensional clinical interventions for Cardio-Kidney-Metabolic (CKM) syndrome. Professor Pan Qi from Beijing Hospital emphasizes that the core advancement lies in breaking the limitations of single-disease treatment, integrating novel medications, technological tools, and multidisciplinary collaboration to achieve a paradigm shift from disease control to systemic protection.First, regarding […]